ACCESSION: MSBNK-SMB_Measured-HSA014P0085005
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 10
COMMENT: RAW_SPEC {'Blanc1-neg_9083': {'bp': 186333.0, 'sum': 234558.0}, 'Blanc1-neg_8603': {'bp': 146734.0, 'sum': 193256.0}, 'Blanc1-neg_8524': {'bp': 138346.0, 'sum': 189648.0}, 'Blanc1-neg_8567': {'bp': 130937.0, 'sum': 167063.0}, 'Blanc1-neg_8411': {'bp': 118029.0, 'sum': 155109.0}, 'Blanc1-neg_8237': {'bp': 99385.0, 'sum': 129737.0}, 'EL02-neg_8563': {'bp': 36254.0, 'sum': 63004.0}, 'EL22-neg_8562': {'bp': 35682.0, 'sum': 63352.0}, 'EL22-neg_8682': {'bp': 35460.0, 'sum': 61315.0}, 'EL02-neg_8711': {'bp': 33124.0, 'sum': 51390.0}}
COMMENT: RETENTION_TIME_STDEV 0.393
COMMENT: PRECURSOR_M/Z_RAW 84.989212
COMMENT: PRECURSOR_M/Z_STDEV 0.000056
COMMENT: PRECURSOR_IN_MS1 mz 84.989314; int 24.102; delta(ppm) 1.130214
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.699; C4F2; [M-H]-; delta(ppm) -23169.478420
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.309; CHF3O; [M-H]-; delta(ppm) -15.969070
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.638; C4F2; [M-H]-; delta(ppm) -23169.478420
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.362; CHF3O; [M-H]-; delta(ppm) -15.969070
COMMENT: CONFIDENCE Level 5: Exact mass of interest 84.989315; Observed in MS1; Charge state Unknown;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 14.518
MS$FOCUSED_ION: PRECURSOR_M/Z 84.989315
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-9000000000-a2632b61d2039fa4fb22
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  83.0237421 65.6330 ? 83.023734 0.7588 33.27 0.7939 10
  84.9892930 999.0000 ? 84.989287 0.4942 0.00 1.0000 10
  87.0073250 39.3621 ? 87.007321 1.0574 18.34 0.9500 9
  99.9244294 230.6924 ? 99.924442 0.9807 95.21 0.9515 10
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  83.023742 65.63 65
  84.989293 999.00 999
  87.007325 39.36 39
  99.924429 230.69 230
//
